MEGAN SKELDING: Open Payments
NPI 1700330958 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 25 payments from 9 companies in 2025. Trend: 2023 $810 · 2024 $593 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 10 | $133 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $14 |
Products named: Azstarys, REXULTI, HETLIOZ, CAPLYTA, TRINTELLIX, SPRAVATO, Auvelity, Qelbree.
Industry payments across IN — which companies pay providers there.
